ArticleComputational and structural biotechnology journal2023

A pathway-based mutation signature to predict the clinical outcomes and response to CTLA-4 inhibitors in melanoma.

Qian Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.